Brief: Iterum Therapeutics Regains Compliance With Nasdaq Bid Price Rule
04/12/2023 13:53
Dec 4 (Reuters) - Iterum Therapeutics PLC ITRM.O :
* ITERUM THERAPEUTICS REGAINS COMPLIANCE WITH NASDAQ BID
PRICE
RULE
Source text for Eikon: ID:nGNX4QySGG
Further company coverage: ITRM.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Iterum Therapeutics
See all newsU.S. STOCKS ON THE MOVE-Entergy, US natgas stocks, Brown-Forman, Datacentrex
U.S. STOCKS ON THE MOVE-Entergy, IDEX Corp, Quanta Services
Iterum Therapeutics plummets after filing wind up petition
Iterum seeks court-led dissolution amid cash crisis, inability to raise funds (updated)
Iterum files wind-up petition due to limited cash, inability to raise equity